Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease.

Respiratory medicine（2023）

引用 0|浏览6

暂无评分

摘要

GOV: NCT02459080; NCT02512510.

查看译文

关键词

COPD,COPD Assessment Test,Clinical COPD Questionnaire,Patient-reported outcomes,Revefenacin,St. George's Respiratory Questionnaire

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要